S'abonner

Characteristics of lymphocyte subsets in HIV-infected, long-term nonprogressor, and healthy Asian children through 12 years of age - 07/08/11

Doi : 10.1016/j.jaci.2010.09.038 
Jintanat Ananworanich, MD, PhD a, b, c, , Tanakorn Apornpong, MSc a, Pope Kosalaraksa, MD d, Tanyathip Jaimulwong, BSc a, Rawiwan Hansudewechakul, MD e, Chitsanu Pancharoen, MD c, Torsak Bunupuradah, MD a, Mom Chandara, MSc f, Thanyawee Puthanakit, MD a, c, Chaiwat Ngampiyasakul, MD g, Jurai Wongsawat, MD h, Suparat Kanjanavanit, MD i, Wicharn Luesomboon, MD j, Phennapha Klangsinsirikul, PhD k, Nicole Ngo-Giang-Huong, PharmD, PhD l, Stephen J. Kerr, PhD a, m, Sasiwimol Ubolyam, MSc a, Tawan Mengthaisong, RN a, Rebecca S. Gelman, PhD n, o, Kovit Pattanapanyasat, PhD p, Vonthanak Saphonn, MD, PhD f, q, Kiat Ruxrungtham, MD, MSc a, c, William T. Shearer, MD, PhD r

PREDICT Study Group

a HIV Netherlands Australia Thailand Research Collaboration, Thai Red Cross AIDS Research Center, Bangkok, Thailand 
b South East Asia Research Collaboration With Hawaii, Bangkok, Thailand 
c Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand 
d Khon Kaen University, Khon Kaen, Thailand 
e Chiangrai Prachanukroh Hospital, Chiang Rai, Thailand 
f National Institute of Public Health, Phnom Penh, Cambodia 
g Prapokklao Hospital, Chantaburi, Thailand 
h Bamrasnaradura Infectious Diseases Institute, Nonthaburi, Thailand 
i Nakornping Hospital, Chiang Mai, Thailand 
j Queen Savang Vadhana Memorial Hospital, Chonburi, Thailand 
k Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailand 
l IRD U174 Program for HIV Prevention and Treatment, Chiang Mai, Thailand 
m National Center in HIV Epidemiology and Clinical Research, Sydney, Australia 
n Harvard School of Public Health, Boston, Mass 
o Dana-Farber Cancer Institute, Boston, Mass 
p Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand 
q National Center for HIV/AIDS, Dermatology and STDs, Phnom Penh, Cambodia 
r Baylor College of Medicine, Houston, Tex 

Reprint requests: Jintanat Ananworanich, MD, PhD, HIV-NAT, Thai Red Cross AIDS Research Center, 104 Rajdumri Rd, Pathumwan, Bangkok, Thailand 10330.

Abstract

Background

There are limited data on the immune profiles of HIV-positive children compared with healthy controls, and no such data for Asian children.

Objectives

To immunophenotype HIV-positive Asian children, including long-term nonprogressors (LTNPs), compared with age-matched healthy controls.

Methods

We used flow cytometry to analyze 13 lymphocyte and monocyte subsets from 222 untreated, HIV-positive children with 15% to 24% CD4+ T cells and no AIDS-related illnesses and 142 healthy children (controls). Data were compared among age categories. Profiles from LTNPs (n = 50), defined as children ≥8 years old with CD4+ T-cell counts ≥350 cells/mm3, were compared with data from age-matched non-LTNPs (n = 17) and controls (n = 53).

Results

Compared with controls, HIV-positive children had lower values (cell count per mm3 and percent distribution) for TH cells and higher values for cytotoxic T cells, with reductions in populations of naive TH and cytotoxic T cells, B cells, and natural killer (NK) cells. HIV-positive children had high values for activated TH and cytotoxic T cells. Compared with non-LTNPs, LTNPs had higher values of TH and cytotoxic T cells, naive and memory T-cell subsets, and B and NK cells. Surprisingly, counts of activated TH and cytotoxic T cells were also higher among LTNPs. LNTPs were more frequently male.

Conclusion

Untreated, HIV-infected Asian children have immune profiles that differ from those of controls, characterized by low values for TH cells, naive T cells, B cells, and NK cells but high values for cytotoxic, activated TH, and cytotoxic T cells. The higher values for activated T cells observed in LTNPs require confirmation in longitudinal studies.

Le texte complet de cet article est disponible en PDF.

Key words : HIV, children, lymphocyte, monocyte, phenotyping, long-term nonprogressors, antiretroviral therapy, Asia, disease progression, pediatric AIDS

Abbreviations used : ART, CDC, IQR, LTNP, NK, OR, PREDICT


Plan


 The PREDICT study was sponsored by the National Institute of Allergy and Infectious Diseases, grant no. U19 AI053741, Clinical%20trial.gov identification number NCT00234091. The lymphocyte subset study in HIV-positive children was sponsored by the National Institute of Allergy and Infectious Disease, grant no. 1R01AI075408-0. The Thai Research Council sponsored the study in healthy children. K.P. is a Thailand Research Fund-Senior Research Scholar. Antiretroviral therapy for PREDICT was provided by GlaxoSmithKline, Boehringer Ingelheim, Merck, Abbott, and Roche.
 Disclosure of potential conflict of interest: K. Ruxrungtham has received research support from the Division of AIDS, National Institute of Allergy and Infectious Disease, NIH. The rest of the authors have declared that they have no conflict of interest.


© 2010  American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 126 - N° 6

P. 1294 - décembre 2010 Retour au numéro
Article précédent Article précédent
  • Innate signals from Nod2 block respiratory tolerance and program TH2-driven allergic inflammation
  • Wei Duan, Amit K. Mehta, Joao G. Magalhaes, Steven F. Ziegler, Chen Dong, Dana J. Philpott, Michael Croft
| Article suivant Article suivant
  • Administration of influenza vaccines to patients with egg allergy: Update for the 2010-2011 season
  • John M. Kelso

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.